Literature DB >> 33475835

Pleural mesothelioma classification update.

Mary Beth Beasley1, Francoise Galateau-Salle2, Sanja Dacic3.   

Abstract

The 2015 WHO classification of pleural mesotheliomas includes three major histologic subtypes-epithelioid, sarcomatoid, and biphasic. Recent genomic data has supported the need for a more granular and clinically valid classification beyond the three current subtypes. Because of tumor rarity and overlapping histologic features with other tumor types, diagnostic immunohistochemical work up is essential component in establishing the final diagnosis of mesothelioma. The use of BAP1 and CDKN2A/MTAP improves the diagnostic sensitivity of effusion specimens and are valuable in establishing the diagnosis of epithelioid mesothelioma. The major change in the forthcoming WHO classification is the inclusion of mesothelioma in situ as a diagnostic category. In this review, we discuss recently proposed changes in the histologic classification of pleural mesothelioma, differential diagnosis, and importance of ancillary diagnostic studies.

Entities:  

Keywords:  Histologic classification; Mesothelioma; Pleura

Mesh:

Substances:

Year:  2021        PMID: 33475835     DOI: 10.1007/s00428-021-03031-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  70 in total

1.  GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.

Authors:  Kyra B Berg; Andrew Churg
Journal:  Am J Surg Pathol       Date:  2017-09       Impact factor: 6.394

2.  SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma.

Authors:  Mahsa S Ahadi; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

3.  Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma.

Authors:  Fouad Sami Alchami; Richard Luther Attanoos; Andrew Richard Bamber
Journal:  J Clin Pathol       Date:  2016-10-18       Impact factor: 3.411

4.  Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.

Authors:  Kyra B Berg; Andrew M Churg; Simon Cheung; Sanja Dacic
Journal:  Cancer Cytopathol       Date:  2019-12-10       Impact factor: 5.284

5.  Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.

Authors:  Kyra B Berg; Sanja Dacic; Caitlyn Miller; Simon Cheung; Andrew Churg
Journal:  Arch Pathol Lab Med       Date:  2018-07-30       Impact factor: 5.534

6.  Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma.

Authors:  Agnes Bilecz; Paul Stockhammer; Dirk Theegarten; Izidor Kern; Marko Jakopovic; Miroslav Samarzija; Thomas Klikovits; Mir A Hoda; Balázs Döme; Felicitas Oberndorfer; Leonhard Muellauer; János Fillinger; Ildikó Kovács; Christine Pirker; Martin Schuler; Till Plönes; Clemens Aigner; Walter Klepetko; Walter Berger; Luka Brcic; Viktória Laszlo; Balazs Hegedus
Journal:  Histopathology       Date:  2020-05-25       Impact factor: 5.087

Review 7.  Malignant Mesothelioma Diagnosis.

Authors:  Qudsia Arif; Aliya N Husain
Journal:  Arch Pathol Lab Med       Date:  2015-08       Impact factor: 5.534

Review 8.  The Diagnosis of Pleural Tumors Other Than Mesothelioma.

Authors:  Richard Luther Attanoos; Matthew Richard Pugh
Journal:  Arch Pathol Lab Med       Date:  2018-08       Impact factor: 5.534

9.  Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues.

Authors:  Sarah Bonk; Martina Kluth; Claudia Hube-Magg; Adam Polonski; Greta Soekeland; Georgia Makropidi-Fraune; Christina Möller-Koop; Melanie Witt; Andreas M Luebke; Andrea Hinsch; Eike Burandt; Stefan Steurer; Till S Clauditz; Thorsten Schlomm; Daniel Perez; Markus Graefen; Hans Heinzer; Hartwig Huland; Jakob R Izbicki; Waldemar Wilczak; Sarah Minner; Guido Sauter; Ronald Simon
Journal:  Oncotarget       Date:  2019-09-10

10.  Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.

Authors:  Juliana Andrici; Amy Sheen; Loretta Sioson; Kathryn Wardell; Adele Clarkson; Nicole Watson; Mahsa S Ahadi; Mahtab Farzin; Christopher W Toon; Anthony J Gill
Journal:  Mod Pathol       Date:  2015-07-31       Impact factor: 7.842

View more
  8 in total

Review 1.  Pleural mesothelioma classification-update and challenges.

Authors:  Sanja Dacic
Journal:  Mod Pathol       Date:  2021-08-31       Impact factor: 7.842

2.  Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review.

Authors:  Francesca Bono; Stefano Ceola; Carlo Beretta; Marta Jaconi
Journal:  Diagnostics (Basel)       Date:  2022-02-01

3.  Novel and Future Treatment Options in Mesothelioma: A Systematic Review.

Authors:  Danijela Štrbac; Vita Dolžan
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

Review 4.  Malignant pleural mesothelioma: an update.

Authors:  Glaucia N M Hajj; Carolina H Cavarson; Clóvis Antônio Lopes Pinto; Gabriela Venturi; João R Navarro; Vladmir C Cordeiro de Lima
Journal:  J Bras Pneumol       Date:  2021-12-13       Impact factor: 2.800

Review 5.  The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma.

Authors:  Valeria Ramundo; Giada Zanirato; Elisabetta Aldieri
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

Review 6.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

7.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 8.  The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis.

Authors:  Federica Volpi; Caterina A D'Amore; Leonardo Colligiani; Alessio Milazzo; Silvia Cavaliere; Annalisa De Liperi; Emanuele Neri; Chiara Romei
Journal:  Diagnostics (Basel)       Date:  2022-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.